RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations
Author:
Affiliation:
1. Allergy Partners of North Texas Research, Dallas, TX, USA
2. Clinical Scientist – PPD Inc., 2400 Research Blvd., Rockville, MD, USA
3. Chief Medical and Scientific Officer- ADMA Biologics Inc., Ramsey, NJ, USA
Funder
AMDA Biologicals, Inc
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2017.1389647
Reference48 articles.
1. Practice parameter for the diagnosis and management of primary immunodeficiency
2. Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data
3. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies
4. Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years
5. Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A molecular perspective for the development of antibodies against the human respiratory syncytial virus;Antiviral Research;2024-02
2. Fc-mediated functions and the treatment of severe respiratory viral infections with passive immunotherapy – a balancing act;Frontiers in Immunology;2023-11-22
3. In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections;Virology;2023-09
4. Respiratory syncytial virus infection and novel interventions;Nature Reviews Microbiology;2023-07-12
5. Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants;Expert Opinion on Pharmacotherapy;2023-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3